BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12707244)

  • 1. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury.
    Schulze CJ; Wang W; Suarez-Pinzon WL; Sawicka J; Sawicki G; Schulz R
    Circulation; 2003 May; 107(19):2487-92. PubMed ID: 12707244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts.
    Sun HY; Xue FS; Xu YC; Li CW; Xiong J; Liao X; Zhang YM
    Chin Med J (Engl); 2009 Dec; 122(24):3048-54. PubMed ID: 20137500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart.
    Lalu MM; Pasini E; Schulze CJ; Ferrari-Vivaldi M; Ferrari-Vivaldi G; Bachetti T; Schulz R
    Eur Heart J; 2005 Jan; 26(1):27-35. PubMed ID: 15615796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
    Fert-Bober J; Leon H; Sawicka J; Basran RS; Devon RM; Schulz R; Sawicki G
    Basic Res Cardiol; 2008 Sep; 103(5):431-43. PubMed ID: 18512095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
    Giricz Z; Lalu MM; Csonka C; Bencsik P; Schulz R; Ferdinandy P
    J Pharmacol Exp Ther; 2006 Jan; 316(1):154-61. PubMed ID: 16166272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in rat myocardium associated with modulation of ischemic tolerance by diazoxide.
    Simoncíková P; Ravingerová T; Andelová E; Tribulová N; Barancík M
    Gen Physiol Biophys; 2007 Jun; 26(2):75-85. PubMed ID: 17660580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of ischaemia determines matrix metalloproteinase-2 activation in the reperfused rabbit heart.
    Prasan AM; McCarron HC; White MY; McLennan SV; Tchen AS; Hambly BD; Jeremy RW
    Proteomics; 2002 Sep; 2(9):1204-10. PubMed ID: 12362337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ischemia/reperfusion and modulation of PI3K/Akt kinase pathway on matrix metalloproteinase-2 in rat hearts.
    Spániková A; Ivanová M; Matejíková J; Ravingerová T; Barancík M
    Gen Physiol Biophys; 2010 Mar; 29(1):31-40. PubMed ID: 20371878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in P-selectin expression on cardiac microvessels in blood-perfused rat hearts subjected to ischemia-reperfusion.
    Chukwuemeka AO; Brown KA; Venn GE; Chambers DJ
    Ann Thorac Surg; 2005 Jan; 79(1):204-11. PubMed ID: 15620944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis.
    Slezak J; Tribulova N; Pristacova J; Uhrik B; Thomas T; Khaper N; Kaul N; Singal PK
    Am J Pathol; 1995 Sep; 147(3):772-81. PubMed ID: 7677188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.
    Deschamps AM; Yarbrough WM; Squires CE; Allen RA; McClister DM; Dowdy KB; McLean JE; Mingoia JT; Sample JA; Mukherjee R; Spinale FG
    Circulation; 2005 Mar; 111(9):1166-74. PubMed ID: 15723986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia-reperfusion injury.
    Sariahmetoglu M; Skrzypiec-Spring M; Youssef N; Jacob-Ferreira AL; Sawicka J; Holmes C; Sawicki G; Schulz R
    Heart; 2012 Apr; 98(8):656-62. PubMed ID: 22397940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ischemia/reperfusion-induced accumulation of matrix metalloproteinases in rat lung by preconditioning with nitric oxide.
    Waldow T; Witt W; Buzin A; Ulmer A; Matschke K
    J Surg Res; 2009 Apr; 152(2):198-208. PubMed ID: 18694576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of tissue inhibitor of metalloproteinase 1 in stunned myocardium.
    Baghelai K; Marktanner R; Dattilo JB; Dattilo MP; Jakoi ER; Yager DR; Makhoul RG; Wechsler AS
    J Surg Res; 1998 Jun; 77(1):35-9. PubMed ID: 9698529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M; Dernek S; Sevin B; Kural T
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway.
    Chan CY; Chen YS; Lee HH; Huang HS; Lai YL; Chen CF; Ma MC
    Life Sci; 2007 Aug; 81(9):717-23. PubMed ID: 17707437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.